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The Expanded Human Kallikrein (KLK) Gene Family:
Genomic Organisation, Tissue-Specific Expression and
Potential Functions
Harvey et al., 2000; Yousef et al., 2000a). Although highly
conserved structurally, their known or predicted enzymic
functions are specific and distinct from one another. They
also share a wide range of expression patterns that likely
indicate involvement in a diverse range of physiological
processes (Bhoola et al., 1992; Clements, 1997; Ritten-
house et al., 1998; Diamandis et al., 2000).
In contrast to the rodent tissue kallikrein (KLK) gene
families, the human KLK gene family appeared to consist
of just three genes – KLK1 encoding tissue kallikrein,
KLK2 encoding glandular kallikrein and KLK3, which en-
codes prostate-specific antigen or PSA (Riegman et al.,
1992; Clements, 1994). These enzymes play important
roles in the (patho)physiology of the kidney, pancreas and
brain and cardiovascular, respiratory, gastrointestinal and
reproductive systems (tissue kallikrein), prostate (PSA
and K2) and breast (PSA) (Bhoola et al., 1992; Clements,
1997; Rittenhouse et al., 1998; Black and Diamandis,
2000). Recently, several groups have identified other hu-
man serine proteases with homology to tissue kallikrein
or PSA (Dihanich and Speiss, 1994; Hansson et al.,1994;
Anisowicz et al., 1996; Liu et al., 1996; Little et al., 1997;
Yamashiro et al., 1997; Yoshida et al., 1998a,b; Brattsand
and Egelrud, 1999; Nelson et al.,1999; Stephenson et al.,
1999; Tanimoto et al., 1999; Underwood et al., 1999; Hu
et al., 2000; Mitsui et al., 2000; Yousef and Diamandis
1999, 2000; Yousef et al., 1999a-c; 2000b-e). All these
genes were clustered at the human KLK locus on chro-
mosome 19q13.4, thus expanding the human KLK gene
family to at least 15 genes (Stephenson et al., 1999; Gan
et al., 2000; Harvey et al., 2000; Yousef et al., 1999a,
2000a). In this review, we summarise briefly the current
knowledge on the structure and function of these genes,
their genomic organisation, sites of expression and
known or predicted physiological roles.
The Human KLK Locus at Proximal 19q13.4
The first three characterised human KLK genes – KLK1,
KLK2 and KLK3 – were localised in a cluster to a 60 kilo-
base region at q13.3 – 13.4 on chromosome 19 (Riegman
et al., 1992; Stephenson et al., 1999). This region is syn-
tenic to the locus on mouse chromosome 7 where the
mouse KLK gene family cluster is localised, further em-
phasising evolutionary similarities between these families
(Howles et al., 1984; Evans et al., 1987). However, the
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The tissue kallikreins are serine proteases encoded
by highly conserved multi-gene families. The rodent
kallikrein (KLK) families are particularly large, con-
sisting of 13 – 26 genes clustered in one chromosomal
locus. It has been recently recognised that the human
KLK gene family is of a similar size (15 genes) with the
identification of another 12 related genes (KLK4-
KLK15) within and adjacent to the original human
KLK locus (KLK1-3) on chromosome 19q13.4. The
structural organisation and size of these new genes is
similar to that of other KLK genes except for addi-
tional exons encoding 5’ or 3’ untranslated regions.
Moreover, many of these genes have multiple mRNA
transcripts, a trait not observed with rodent genes.
Unlike all other kallikreins, the KLK4-KLK15 encoded
proteases are less related (25– 44%) and do not con-
tain a conventional kallikrein loop. Clusters of genes
exhibit high prostatic (KLK2-4, KLK15) or pancreatic
(KLK6-13) expression, suggesting evolutionary con-
servation of elements conferring tissue specificity.
These genes are also expressed, to varying degrees,
in a wider range of tissues suggesting a functional in-
volvement of these newer human kallikrein proteases
in a diverse range of physiological processes.
Key words: Gene family/Gene structure /KLK /
Tissue Kallikrein/Tissue specificity.
Introduction
The tissue kallikreins are a subgroup of serine proteas-
esw that are characterised by their homology to true tis-
sue kallikrein, encoded by the KLK1 gene (Clements,
1989, 1997; Bhoola et al., 1992). Typically, they share a
high degree of sequence and structural similarity and, at
least in three species – mouse, rat and man – the genes
are clustered together at one locus (Evans et al., 1987;
Southard-Smith et al., 1994; Kurtz and St.Lezin, 1992;
Brought to you by | University of Queensland - UQ Library
Authenticated
Download Date | 9/14/15 3:58 AM
striking difference between the mouse (and rat) and hu-
man KLK families was their size. The rodent families are
large consisting of 13– 26 genes (Evans et al., 1987;
Wines et al., 1989); the rat family is also clustered in one
locus on rat chromosome 1 (Kurtz and St.Lezin, 1992;
Southard-Smith et al., 1994). Thus, by comparison, it ap-
peared logical that the human KLK family may also con-
tain more genes specifically within, or adjacent to, the
original KLK cluster on 19q13.3– 13.4. Early genomic
Southern blot analyses presented conflicting results with
most groups suggesting there were only 3 – 4 genes
(Baker and Shine, 1985; Fukushima et al., 1985; Evans et
al., 1988; Riegman et al., 1989). However, Southern blot
analyses of a human genomic library, using a monkey
KLK cDNA probe with 92 – 95% homology to human KLK
cDNAs, indicated that there may be as many as 19 hu-
man KLK genes (Murray et al., 1990).
Subsequently, several newly characterised human ser-
ine proteases – Protease M/neurosin/zyme, normal ep-
ithelial cell-specific 1 (Nes 1), trypsin-like serine protease
(TLSP), stratum corneum chymotryptic enzyme (SCCE),
and neuropsin – were identified to have some homology
(~40%) to tissue kallikrein or PSA (Hansson et al., 1994;
Anisowicz et al., 1996; Liu et al., 1996; Little et al., 1997;
Yamashiro et al., 1997; Yoshida et al., 1998a,b). Although
these enzymes are less related than tissue kallikrein, K2
and PSA (62 – 77%) are to each other, two of the encod-
ing genes were localised by FISH analysis to
19q13.3– 13.4, in the vicinity of the KLK locus (Anisowicz
et al., 1996; Little et al., 1997; Luo et al., 1998). This sug-
gested that indeed there were other serine protease
genes in this region but that they were less related to the
KLK1-3 encoded proteases in sharp comparison to the
high conservation observed between the rodent
kallikreins (70 – 85%) (Evans et al., 1987; Wines et al.,
1989).
Recently, both the availability of the draft sequence for
this region from the Human Genome Sequencing Project
(at Lawrence Livermore National Laboratory, California,
USA) and physical mapping has allowed the identifica-
tion of 12 additional kallikrein-related genes (KLK4 – 15)
within a 320 kilobase region that encompasses the origi-
nal KLK locus (Gan et al., 2000; Harvey et al., 2000;
Yousef et al., 1999a, 2000a). Although many of these new
genes/proteases are known by a variety of designations
(see above and Table 1), the Human Genome Nomencla-
ture Committee recently approved the use of the consis-
tent KLK nomenclature to describe these genes (Diaman-
dis et al., 2000b). KLK4 – 14 lie telomeric of the original
locus and are transcribed telomere to centromere in the
same direction as KLK1 (Figure 1). KLK15 lies between
KLK1 and KLK3 and is also transcribed in the same di-
rection as KLK1. KLK2 and KLK3 are the only two genes
in the locus that are transcribed in the opposite direction
– centromere to telomere. Like the rodent families that
contain 3 (rat) to 10 (mouse) pseudogenes (Berg et al.,
1992), 5 pseudogene sequences have been identified
surrounding the KLK3-KLK2-KLK4 cluster at the cen-
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Table 1 Summary of the mRNA Expression Patterns of the 15 KLK Genes Obtained by Northern Blot and RT-PCR Analysis.
Northern and mRNA dot blot tissue expression RT-PCR tissue expression
Current Other High Moderate High Moderate
name names
KLK1 Tissue kallikrein Kidney Endometrium r Prostate r
Pancreas Kidney r Salivary gland r
Salivary gland Ovary r
KLK2 Glandular kallikrein Prostate Prostate r
KLK3 PSA Prostate Prostate r
KLK4 Prostase Prostate Prostate r Endometrium r
PRSS17 Ovary r Salivary gland r
KLK-like1 Kidney r
Uterus
Breast
Adrenal gland
Colon
Thyroid
Testis
KLK5 KLK-like Testis Salivary gland Skin r Breast r
SCTE Breast Esophagus Endometrium r Kidney
Skin Ovary r Brain
KLK6 Protease M Pancreas Spinal cord Breast r Salivary gland
Neurosin Brain Testis Skin r Heart
Zyme Kidney Appendix Endometrium r Thyroid
PRSS9 Colorectal adenocarcinoma Kidney Spleen
Ovary r Placenta
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The Expanded Human KLK Gene Family 7
Prostate r Testis
Brain Trachea
Uterus
Thymus
Spinal cord
Kidney
KLK7 SCCE Pancreas Breast r Prostate
PRSS6 Skin Skin r Kidney
Endometrium r
Ovary r
KLK8 Neuropsin Pancreas Duodenum Endometrium r Breast r
TADG-14 Brain Liver Ovary r Prostate r
Ovasin Skin Esophagus Skin r Salivary gland
PRSS19 Stomach
Salivary gland
KLK9 KLK-like 3 Pancreas Salivary gland Prostate
Thymus Breast
Testis Trachea
Spinal cord
KLK10 Nes 1 Pancreas Esophagus Breast r
PRSSL1 Breast Duodenum Skin r
Ovary Trachea Endometrium r
Colon Colorectal adenocarcinoma Prostate
Small intestine Prostate Ovary r
Testis
Lung
KLK11 TLSP Pancreas Salivary gland Skin r Breast r
PRSS20 Skin Stomach Prostate Stomach
Hippostasin Prostate Liver Salivary gland Uterus
Lung Skeletal muscle Ovary r Lung
Heart Brain Spleen
Testis Cerebellum
Brain
KLK12 KLK-like 5 Pancreas Brain Salivary gland r
Duodenum
Appendix
KLK13 KLK-like 4 Pancreas Duodenum Endometrium r Breast r
Esophagus Stomach Prostate Skin r
Appendix Brain Salivary gland
Testis Ovary r
Prostate
Salivary gland
KLK14 KLK-like 6 Brain Liver Breast r
Bone marrow Pancreas Skin r
Fetal liver Fetal spleen Endometrium r
Prostate Prostate
Salivary gland r
Ovary r
KLK15 KLK15 Salivary gland Adrenal gland
Prostate Colon
Thyroid Testis
Kidney
The Northern blot expression patterns are mostly from tissues except for the cell line, colorectal adenocarcinoma, whereas the RT-PCR
patterns are from tissues and carcinoma cell lines; (r) represents carcinoma cell lines. All references used in the preparation of this Table
are highlighted throughout the text.
Table 1 (continued)
Northern and mRNA dot blot tissue expression RT-PCR tissue expression
Current Other High Moderate High Moderate
name names
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tromeric end of the locus (Stephenson et al.,1999; Gan et
al., 2000). The locus lies between intervals D19S425 to
D19S418 at proximal q13.4. Specific microsatellite mark-
ers that are associated with the locus are WI-9055,
M21896 and U37672 (KLK3); stSG39975 and sts-
S39329 (KLK2); WI-20869 (KLK6) and stSG30247
(KLK10) (Harvey et al., 2000) (Figure 1).
Genomic Southern blot analysis of bacterial artificial
chromosomes (BACs) containing DNA from this region,
with a degenerate probe to the histidine-encoding region
of serine proteases, suggests that most, if not all, serine
protease genes in this region have been identified (Har-
vey et al., 2000). In support of this, the next gene telom-
eric of KLK14 is an unrelated gene, SIGLEC9, which en-
codes a sialic acid-binding Ig-like lectin that is also a
member of the immunoglobulin superfamily (Foussias et
al., 2000). However, draft sequence is not yet available for
the region centromeric of KLK1 and KLK3, thus there
may still be further as yet unidentified genes within the
KLK locus.
Structural and Sequence Similarities
The size of the human KLK genes range from 4 – 10 kilo-
bases with most of the differences relating to differences
in intron sizes, although the intron phases are completely
conserved (Luo et al.,1998; Nelson et al., 1999; Stephen-
son et al., 1999, Yousef and Diamandis 1999, 2000;
Yousef et al., 1999b,c, 2000a–e; Hu et al., 2000) (Table 2).
Of note, the five coding exons for these serine protease
genes are highly conserved both in size and organisation.
The first of these has a short 5’ untranslated region prior
to the initiation of the pre-signal peptide coding region.
The second exon encodes the remainder of the pre- as
well as pro-enzyme sequences. The mature enzyme is
encoded on the remainder of the second coding exon
through to the fifth coding exon with a variable sized 3’
untranslated region completing this last coding exon. The
positions, in the second, third and fifth coding exons, of
the three residues of the catalytic triad (histidine, aspar-
tate, serine) critical for protease activity are highly con-
served across all 15 genes. Interestingly, this structural
organisation is also highly conserved for all rodent KLK
genes and the dog KLK2 gene (Evans et al., 1987, Wines
et al., 1989, 1991; Chapdelaine et al., 1991).
The major structural difference between these newer
human KLK genes and the original KLK1 – 3 genes or
those of other species is the presence of additional exons
either 5’ or 3’ of the coding exons for many of these
genes (Luo et al.,1998; Hu et al., 2000; Mitsui et al.,2000;
Yousef and Diamandis 1999; Yousef et al., 1999b;
200a,c,d,e). Since the transcriptional start site or TATA
box elements have not yet been delineated for all of these
genes, it is possible that additional 5’ exons may be pres-
ent in more genes. The mRNA transcript sizes vary from
~870 to ~1600 nucleotides with variable 5’ and 3’ un-
translated regions determining the variable length. Both
classical (AATAAA) and variant (AGTAAA, ACTAAA,
TATAAA, ATTAAA) polyadenylation signals are utilised.
Multiple variant mRNA transcripts, the result of alterna-
tive splicing, have also been described for many of the hu-
man KLK genes (Chen et al., 1994; Rae et al., 1999; Rieg-
man et al., 1988, 1991; Liu et al.,1999; Heuze et al.,1999;
Tanaka et al., 2000; Yousef et al., 2000b,d,e; Mitsui et al.,
2000). This is in sharp contrast to the rodent families
where only one mRNA transcript has been described for
each gene (Evans et al., 1987; Wines et al., 1989). These
splicing events cause a shift in the open reading frame,
leading to premature stop codons and truncated proteins
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Fig. 1 Location of the KLK Locus at Chromosome 19q13.3– 13.4.
(A) Schematic representation of the interval between D19S425 and D19S418 including 19q13.3 – 13.4. The KLK locus is located proxi-
mal to D19S418. B. The position of the 15 kallikrein encoding genes on the KLK locus are marked. KLK1 and KLK4 to KLK15 are tran-
scribed telomere to centromere, whereas KLK2 and KLK3 are transcribed in the opposite direction. The position of microsatellite mark-
ers relative to these genes in the KLK locus are also indicated.
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if translated. These variant transcripts would not encode
functional serine proteases as typically one or other of the
three residues critical for catalytic activity is missing. The
degree of tissue-specificity in expression of these alterna-
tively spliced mRNAs or protein products or their relation-
ship to a particular pathophysiological condition is yet to
be determined. Whether these events represent a means
of further functional diversification of the human KLK
gene family or is a control mechanism for regulating levels
of the native protein or is simply an unrelated genomic
processing event requires further clarification.
In contrast to the rodent KLK/Klk families and the hu-
man KLK1–KLK3 encoded enzymes which are highly
conserved (rodents: 70 – 85%; K1–K2: 62 – 77%), the
newer human K4–K15 enzymes are less related
(25 – 44%) (Figure 2). This may reflect an evolutionary or-
der of gene duplication within this locus with the
KLK1–KLK3 genes perhaps the result of the most recent
duplication. In keeping with this observation, phylogenet-
ic analysis of the human KLK locus suggests that there
are a number of sub-groups within this family (Figure 3).
As noted above, key residues (and much of the adjacent
regions) that denote serine protease activity are entirely
conserved (Figure 2). The majority of these enzymes are
trypsin-like in action, a function denoted by an aspartate
six residues before the catalytic serine; four enzymes (K3,
K7, K9, K15) have alternate residues in this position
which likely denotes a chymotrypsin-like action. Ten of
the disulfide bond-forming cysteines are absolutely con-
served amongst the 15 kallikreins. A sixth bridge forming
cysteine pair is conserved in K4–K12 and K14–K15, but
is lacking in K1–K3 and K13 (Figure 2). K1–K3 also con-
tain an insertion of 11 amino acids prior to the catalytic
aspartate, denoted the kallikrein loop, that is thought to
be important for substrate specificity of these enzymes.
The newer proteases do not have this loop region al-
though five of them have smaller insertions (Figure 2) that
also may be important in specifying their enzymic action.
Tissue-Specific Patterns of Expression
As with the rat KLK family (MacDonald et al., 1996), the
newer members of the human KLK gene family are ex-
pressed in a large number of tissues, particularly when
expression patterns are examined using the sensitive re-
verse-transcription-polymerase chain reaction (RT-PCR)
(Brattsand and Egelrud, 1999; Yousef and Diamandis
1999, 2000; Yousef et al., 1999b,c, 2000b–e; Harvey et
al., 2000) (Table 1). However, the number of tissues in
which they are most highly expressed, as delineated us-
ing Northern and mRNA dot blot analysis, is more re-
stricted and surprisingly conserved. In comparison to the
well described KLK1 gene, that is highly expressed in the
salivary gland, kidney and pancreas (Baker and Shine,
1985; Fukushima et al., 1985; Evans et al., 1988), no oth-
er genes exhibit that precise pattern of expression, al-
though, the KLK6 gene is highly expressed in the brain,
kidney and pancreas (Anisowicz et al., 1996; Little et al.,
1997; Harvey et al., 2000). Additionally, several other
genes are highly expressed in the pancreas (KLK7 – 13;
Liu et al., 1996; Harvey et al., 2000). Of interest is the
clustering of these eight genes within the locus perhaps
indicating conservation of promoter elements conferring
tissue specific expression or a common locus control re-
gion. Indeed, a pancreatic-specific-like sequence similar
to that identified in other rat pancreatic serine proteases
(Swift et al., 1984; Boulet et al., 1986) has been identified
in the promoter of the rodent and human KLK1 genes
(Wines et al., 1989).
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Table 2 Comparison of the Genomic Structures of the Human Kallikrein Genes KLK1–KLK15.
Gene Exon Intron Exon Intron [5’UTR] Intron His Intron Asp Intron Exon Intron Ser Intron Exon
Exon Exon Exon Exon 
[3’UTR]
KLK1 [39] 46 1829 (I) 160 1269 (II) 290 118 (I) 137 548 (O) 156 [46]
KLK2 [29] 46 1206 (I) 160 1589 (II) 287 113 (I) 137 1393 (O) 156 [674]
KLK3 [41] 46 1238 (I) 160 1637 (II) 287 143 (I) 137 1376 (O) 156 [637]
KLK4 49 587 [11] 61 1263 (I) 163 421 (II) 251 83 (I) 137 1272 (O) 153 [603]
KLK5 31 78 [11] 73 2468 (I) 262 739 (II) 257 85 (I) 134 4853 (O) 156 [323]
KLK6 185 898 52 423 [8] 40 739 (I) 157 3519 (II) 248 1421 (I) 137 1877 (O) 153 [526]
KLK7 30 1393 [58] 73 412 (I) 148 696 (II) 248 315 (I) 137 2096 (O) 156 [748]
KLK8 171 356 [8] 70 514 (I) 160 165 (II) 263 2097 (I) 134 1536 (O) 156 [45]
KLK9 [87] 43 165 (I) 157 2459 (II) 160 2723 (I) 137 443 (O) 150 [598]
KLK10 73 484 [9] 88 1753 (I) 181 953 (II) 275 331 (I) 134 464 (O) 153 [529]
KLK11 86 1790 [35] 40 797 (I) 157 327 (II) 266 816 (I) 137 394 (O) 153 [312]
KLK12 98 154 [19] 37 445 (I) 160 1844 (II) 260 954 (I) 134 1330 (O) 156 [210]
KLK13 [43] 52 4396 (I) 187 339 (II) 269 1150 (I) 137 1762 (O) 189 [381]
KLK14a 69 85 [22] 40 871 (I) 172 1829 (II) 254 497 (I) 137 655 (O) 153 [177] 254 259
KLK15 [55] 43 3635 (I) 154 500 (II) 284 120 (I) 137 673 (O) 153 [507]
Bracketed numeral indicates intron phase. Coding exons are indicated by bold letters.
a Unpublished data: KLK14 Genbank accession number AF283669.
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Furthermore, the KLK4 gene exhibits an identical ex-
pression pattern to that of the previously characterised
KLK2 and KLK3 genes with abundant expression re-
stricted to the prostate (Chapdelaine et al., 1988; Rieg-
man et al., 1988; Nelson et al., 1999; Stephenson et al.,
1999, Harvey et al., 2000). KLK2 – 4 are clustered togeth-
er in the locus and the promoters of KLK2 and KLK3 have
been extensively characterised and show a high degree
of conservation (Wolf et al., 1992; Murtha et al., 1993;
Cleutjens et al., 1997; Sun et al., 1997). By Northern and
mRNA dot blot analysis, other tissues in which KLK ex-
pression is abundant are the brain (KLK8, KLK11,
KLK14), skin (KLK5, KLK7, KLK8, KLK11), lung (KLK10,
KLK11), heart (KLK11), testis (KLK5, KLK10, KLK11),
mammary gland (KLK5, KLK10), ovary, small intestine
and colon (KLK10) (Anisowicz et al.,1996; Liu et al.,1996;
Yoshida et al., 1998; Brattsand and Egelrud, 1999; Har-
vey et al., 2000; Mitsui et al., 2000). KLK5, KLK6, KLK8,
KLK10 are also expressed at high levels, at the mRNA
level, in ovarian or breast cancer carcinomas or cell lines
(Anisowicz et al., 1996; Liu et al., 1996; Tanimoto et al.,
1999; Underwood et al., 1999). In addition to these sites
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Fig. 2 Multiple Sequence Alignment of Human Kallikrein Serine Proteases.
Residues which are identical between at least eight of the enzymes are boxed. Catalytic residues are indicated by filled boxes. Disul-
fide bond forming cysteines are indicated by filled circles. The residue located at the bottom of the substrate binding pocket is indicat-
ed by a circle. The kallikrein loop region is overlined. The activation site is indicated by a filled triangle. The alignment was performed
using the PileUp program. GenBank accession numbers: K1, M33105; K2, M18157; K3, M26663; K4, AF148532; K5, AF135028; K6,
U62801; K7, L33404; K8, AB009849; K9, AF135026; K10, AF024605; K11, AB012917; K12, AF135025; K13, AF135024; K14,
AF283669; K15, AF242195.
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of high expression, RT-PCR analysis demonstrates that
these newer KLK genes are also expressed in a range of
other tissues including salivary gland, trachea, esopha-
gus, spinal cord, thymus, appendix, spleen, bone mar-
row, adrenal gland, thyroid, uterus, placenta and fetal or-
gans as well as several carcinoma cell lines (Brattsund
and Egelrud, 1999; Yousef and Diamandis, 1999, 2000;
Yousef et al., 1999a–c; 2000b–e; Harvey et al., 2000).
Known and Putative Functions
From the combined Northern blot and RT-PCR data, it is
clear that this family of genes is expressed to varying de-
grees in a large number of tissues and are likely to be im-
portant in a diverse range of patho(physiological)
processes. The roles of the first three KLK family mem-
bers to be identified – tissue kallikrein or K1, K2 and PSA
– are well described. Tissue kallikrein, through the gener-
ation of (lys)bradykinin, and a ubiquitous expression pat-
tern, is involved in the function of most systems in the
body (Bhoola et al., 1992; Clements, 1997). There is
some in vitro evidence that tissue kallikrein may act on a
range of other substrates such as the matrix metallopro-
teases (Tschesche et al., 1989), but these are not proven
biological functions. PSA hydrolyses seminal vesicle pro-
teins in ejaculate, an event that is integral to sperm motil-
ity (Lilja, 1985). Like tissue kallikrein, PSA is also suggest-
ed to act on several other substrates (Rittenhouse et al.,
1998) but the biological relevance of these findings is not
yet clear. PSA is widely used as a diagnostic marker for
prostate cancer and monitoring tumour recurrence (Fry-
denberg et al., 1997). Of interest, PSA expression is also
associated with breast disease (Yu et al., 1996) and PSA
has been recently suggested to be a useful prognostic
marker for breast cancer (Black and Diamandis, 2000).
K2, to a lesser degree, is also being examined as a diag-
nostic/prognostic marker for prostate disease (Young et
al., Recker et al., 1998). K2 activates pro-urinary plas-
minogen activator and thus plays a role in matrix degra-
dation and cancer invasion (Frenette et al., 1997). K2 can
also activate pro-PSA (Lovgren et al., 1997; Kumar et al.,
1997; Takayama et al., 1997), demonstrating the close re-
lationship of these two prostatic kallikreins.
The enzymatic functions of nearly all of the newer KLK-
encoded proteins are not yet known. The exception is K6
or zyme that can hydrolyse amyloid precursor protein
and thus is hypothesised to be important in the deposi-
tion of amyloid plaques in Alzheimer’s disease (Little et
al., 1997). Interestingly, the KLK6 gene is also highly ex-
pressed in breast and ovarian cancers (Anisowicz et al.,
1996; Yousef et al., 1999b). Although the function of K6 in
these malignancies is yet to be established, these find-
ings highlight the potential for diverse, perhaps tissue-
specific, roles for these enzymes. As noted above, the
expression of several other KLK genes in breast, ovarian
and prostate cancer tissues or cell lines (Anisowicz et al.,
1996; Nelson et al., 1999; Tanimoto et al., 1999; Under-
wood et al., 1999; Yousef and Diamandis, 1999, 2000;
Yousef et al., 1999b, c; 2000b–e; Gan et al., 2000; Harvey
et al., 2000) demonstrates that many members of this
family of serine proteases are associated with hormone-
dependent cancers (Diamandis et al., 2000). Whether
these enzymes, like PSA and K2, may be useful diagnos-
tic or prognostic markers for these diseases or play im-
portant roles in cancer progression is yet to be estab-
lished. Interestingly, KLK10 is suggested to play a tumour
suppressor role in breast and prostate cancer (Goyal et
al., 1998).
Similarly, the isolation or cloning of these enzymes
from specific tissues such as the skin (KLK5, KLK7,
KLK11) and brain (KLK6, KLK8, KLK11) suggests a role at
these sites, although this is yet to be elucidated. Several
of these genes (KLK5, KLK6, KLK9) are also expressed in
psoriatic lesions further emphasising their involvement in
the (patho)physiology of the skin (Gan et al., 2000). Of in-
terest, in a manner analagous to that of the prostatic K2
and PSA enzymes, the co-localisation of the trypsin-like
K5 and chymotrypsin-like K7 enzymes in skin has led to
the proposal that K5 may be the activator of K7 in this tis-
sue (Brattsand and Egelrud, 1999). As noted above, the
high expression of the KLK6–KLK13 cluster in the pan-
creas (Harvey et al., 2000) presumably also suggests an
important role in pancreatic function for these enzymes.
Other functions, in teeth development and neural plastic-
ity, have been suggested for the K4 and K8 enzymes re-
spectively, by extrapolation of the known actions of their
putative mouse orthologues – enamel matrix serine pro-
tease and neuropsin (Hu et al., 2000; Yoshida et al.,
1998).
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Fig. 3 Phylogenetic Tree of the Expanded KLK Family.
The tree was generated from an Eclustal multiple sequence
alignment of the 15 kallikrein proteins using the Dayhoff program
of the Phylip package. The lower the branch number the more
closely related the genes.
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Conclusion
The expanded human KLK serine proteases, although
encoded by a large multigene family as in rodents, are
less conserved than their rodent counterparts. Their
largely disparate but overlapping expression patterns in-
dicate that these enzymes are likely to be involved in the
(patho)physiology of a range of different organs. The
challenge now is to precisely determine the enzymic ac-
tion of these proteases and their biological roles in these
tissues and to assess their viability as diagnostic markers
for a number of disease states.
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